{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:29:25Z","timestamp":1777130965753,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Myasthenia Gravis Foundation of IL","award":["R01 AI072040"],"award-info":[{"award-number":["R01 AI072040"]}]},{"DOI":"10.13039\/100007393","name":"Association Francaise contre les Myopathies","doi-asserted-by":"publisher","award":["14473"],"award-info":[{"award-number":["14473"]}],"id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["217696"],"award-info":[{"award-number":["217696"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jneuroim.2015.03.004","type":"journal-article","created":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T05:24:48Z","timestamp":1425619488000},"page":"68-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB\/c mice"],"prefix":"10.1016","volume":"281","author":[{"given":"Ruksana","family":"Huda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard T.","family":"Strait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdem","family":"T\u00fcz\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred D.","family":"Finkelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Premkumar","family":"Christadoss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jneuroim.2015.03.004_bb0020","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cellimm.2011.07.007","article-title":"Characterization of peripheral blood acetylcholine receptor-binding B cells in experimental myasthenia gravis","volume":"271","author":"Allman","year":"2011","journal-title":"Cell. Immunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2015.03.004_bb0075","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1084\/jem.152.3.507","article-title":"Linkage between the frequency of muscular weakness and loci that regulate immune responsiveness in murine experimental myasthenia gravis","volume":"152","author":"Berman","year":"1980","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2015.03.004_bb0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/clim.1999.4807","article-title":"Animal models of myasthenia gravis","volume":"94","author":"Christadoss","year":"2000","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2015.03.004_bb0100","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4049\/jimmunol.169.2.1077","article-title":"Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production","volume":"169","author":"Deng","year":"2002","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.jneuroim.2015.03.004_bb0105","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.4049\/jimmunol.174.9.5324","article-title":"Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis","volume":"174","author":"Feferman","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.03.004_bb0070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/263329a0","article-title":"Strain differences in the autoimmune response of mice to acetylcholine receptors","volume":"263","author":"Fuchs","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2015.03.004_bb0065","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2249.1993.tb03429.x","article-title":"Characterization of anti-acetylcholine receptor (AChR) antibodies from mice differing in susceptibility for experimental autoimmune myasthenia gravis (EAMG)","volume":"92","author":"Graus","year":"1993","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.jneuroim.2015.03.004_bb0005","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bbadis.2014.11.022","article-title":"Myasthenia gravis and related disorders: pathology and molecular pathogenesis","volume":"1852","author":"Ha","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jneuroim.2015.03.004_bb0095","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaut.2013.01.003","article-title":"Complement C2 siRNA mediated therapy of myasthenia gravis in mice","volume":"42","author":"Huda","year":"2013","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.jneuroim.2015.03.004_bb0010","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1515\/revneuro-2014-0021","article-title":"Targeting complement system to treat myasthenia gravis","volume":"25","author":"Huda","year":"2014","journal-title":"Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.jneuroim.2015.03.004_bb0025","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1128\/iai.63.2.410-415.1995","article-title":"Immunoglobulin G1 (IgG1) and IgG3 antibodies are markers of progressive disease in leprosy","volume":"63","author":"Hussain","year":"1995","journal-title":"Infect. Immun."},{"issue":"5097","key":"10.1016\/j.jneuroim.2015.03.004_bb0080","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1126\/science.8438159","article-title":"Shutdown of class switch recombination by deletion of a switch region control element","volume":"259","author":"Jung","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2015.03.004_bb0040","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1749-6632.2012.06783.x","article-title":"The role of complement in experimental autoimmune myasthenia gravis","volume":"1274","author":"Kusner","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2015.03.004_bb0110","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.4049\/jimmunol.168.7.3437","volume":"168","author":"McLay","year":"2002","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2015.03.004_bb0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/eji.200535178","article-title":"A mutant human IgG molecule with only one C1q binding site can activate complement and induce lysis of target cells","volume":"36","author":"Michaelsen","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.03.004_bb0035","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1212\/WNL.43.6.1167","article-title":"Myasthenia gravis: quantitative immunocytochemical analysis of inflammatory cells and detection of complement membrane attack complex at the end-plate in 30 patients","volume":"43","author":"Nakano","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2015.03.004_bb0030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-065X.2010.00910.x","article-title":"Antibody-mediated modulation of immune responses","volume":"236","author":"Nimmerjahn","year":"2010","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.jneuroim.2015.03.004_bb0055","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2567.1998.00472.x","article-title":"Activation of complement by human IgG1 and human IgG3 antibodies against the human leucocyte antigen CD52","volume":"93","author":"Redpath","year":"1998","journal-title":"Immunology"},{"issue":"7535","key":"10.1016\/j.jneuroim.2015.03.004_bb0125","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nature13868","article-title":"IgG1 protects against renal disease in a mouse model of cryoglobulinemia, 2015","volume":"517","author":"Strait","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2015.03.004_bb0120","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4049\/jimmunol.147.2.515","article-title":"IgG3 production in MRL\/lpr mice is responsible for development of lupus nephritis","volume":"147","author":"Takahashi","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.03.004_bb0115","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.4049\/jimmunol.175.10.6909","article-title":"The role of complement in cryoglobulin-induced immune complex glomerulonephritis","volume":"175","author":"Trendelenburg","year":"2005","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.jneuroim.2015.03.004_bb0045","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.autrev.2013.03.003","article-title":"Complement associated pathogenic mechanisms in myasthenia gravis","volume":"12","author":"T\u00fcz\u00fcn","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2015.03.004_bb0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1749-6632.2012.06773.x","article-title":"Novel animal models of acetylcholine receptor antibody-related myasthenia gravis","volume":"1274","author":"T\u00fcz\u00fcn","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2015.03.004_bb0085","doi-asserted-by":"crossref","first-page":"15.8.1","DOI":"10.1002\/0471142735.im1508s100","article-title":"Experimental autoimmune myasthenia gravis in the mouse","volume":"100","author":"Wu","year":"2013","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.jneuroim.2015.03.004_bb0090","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.4049\/jimmunol.175.3.2018","article-title":"IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1","volume":"175","author":"Yang","year":"2005","journal-title":"J. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281500051X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281500051X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:24:48Z","timestamp":1759047888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557281500051X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":25,"alternative-id":["S016557281500051X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.03.004","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}